医学
多囊卵巢
妇科
子宫内膜增生
孕激素
保持生育能力
生育率
子宫切除术
卵巢
子宫内膜
非典型增生
增生
产科
外科
内科学
雌激素
人口
环境卫生
胰岛素抵抗
胰岛素
作者
Donatella Caserta,Eleonora Matteucci,Eleonora Ralli,Maddalena Mallozzi,Giulia Bordi,Massimo Mangino
出处
期刊:PubMed
日期:2014-01-01
卷期号:35 (1): 97-9
被引量:1
摘要
The standard treatment for complex atypical hyperplasia is hysterectomy and bilateral salpingo-oophorectomy. Although radical surgery offers high survival prospects, it also eliminates any chance of further fertility, thus in young nulliparous women who wish to preserve their childbearing potential, a conservative progestin therapy is preferable.The authors report a case of complex atypical hyperplasia in a 29-year-old nulliparous woman with polycystic ovary syndrome treated with norethisterone acetate in order to preserve her childbearing potential. The specimens sampled during the follow-up demonstrated inactive endometrium with pseudodecidual changes and no ultrasonographic images exhibited abnormal endometrial thickness.According to literature and to the authors' experience, they can affirm that progestin treatment is the most reasonable option for young nulliparous women affected by complex atypical hyperplasia who desire to maintain their fertility potential, showing its efficacy also in patients with an associated polycystic ovary syndrome.
科研通智能强力驱动
Strongly Powered by AbleSci AI